Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Ginkgo Bioworks Hldgs Inc (DNA)
Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,441,074
  • Shares Outstanding, K 2,085,499
  • Annual Sales, $ 477,710 K
  • Annual Income, $ -2,105 M
  • 60-Month Beta 0.89
  • Price/Sales 7.07
  • Price/Cash Flow N/A
  • Price/Book 2.17
Trade DNA with:

Options Overview Details

View History
  • Implied Volatility 82.59% ( -10.15%)
  • Historical Volatility 94.74%
  • IV Percentile 10%
  • IV Rank 32.87%
  • IV High 146.96% on 08/11/22
  • IV Low 51.07% on 04/14/23
  • Put/Call Vol Ratio 1.22
  • Today's Volume 20,025
  • Volume Avg (30-Day) 6,069
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 254,116
  • Open Int (30-Day) 233,293

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -0.09
  • Number of Estimates 4
  • High Estimate -0.08
  • Low Estimate -0.10
  • Prior Year -0.41
  • Growth Rate Est. (year over year) +78.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2000 +53.75%
on 05/17/23
1.8500 -0.27%
on 06/06/23
+0.5750 (+45.28%)
since 05/05/23
3-Month
1.1200 +64.73%
on 05/03/23
1.8500 -0.27%
on 06/06/23
+0.4850 (+35.66%)
since 03/06/23
52-Week
1.1200 +64.73%
on 05/03/23
4.9100 -62.42%
on 08/11/22
-1.6250 (-46.83%)
since 06/06/22

Most Recent Stories

More News
Ginkgo Bioworks Announces Participation in Goldman Sachs 44th Annual Global Healthcare Conference

/PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, announced...

DNA : 1.8350 (+11.21%)
Ginkgo Bioworks and Centrient Pharmaceuticals Announce Expansion of Partnership Following Success of Initial Project to Bring Sustainable Innovation to the Generic API Space

/PRNewswire/ -- Centrient Pharmaceuticals ("Centrient"), the global business-to-business leader in sustainable antibiotics, next-generation statins and...

DNA : 1.8350 (+11.21%)
3 Reasons Why Cathie Wood Is Buying Ginkgo Bioworks Stock Hand Over Fist

The price is right and its future is bright -- but there are risks, too.

DNA : 1.8350 (+11.21%)
ARKK : 42.59 (+1.26%)
3 Key Biotech Trends for 2023 And Beyond

New opportunities are becoming apparent, but so are fresh risks in the biotech field.

SDGR : 38.40 (+0.68%)
ME : 2.05 (-1.44%)
DNA : 1.8350 (+11.21%)
Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q1 Loss, Tops Revenue Estimates

Ginkgo Bioworks Holdings, Inc. (DNA) delivered earnings and revenue surprises of 11.11% and 30.07%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the...

DNA : 1.8350 (+11.21%)
BOLT : 1.6600 (-1.19%)
Ginkgo Bioworks Reports First Quarter 2023 Financial Results

/PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today...

DNA : 1.8350 (+11.21%)
Anika Therapeutics (ANIK) Reports Q1 Loss, Tops Revenue Estimates

Anika (ANIK) delivered earnings and revenue surprises of -97.22% and 2.05%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ANIK : 26.86 (+0.49%)
DNA : 1.8350 (+11.21%)
Ginkgo Bioworks Partners with Boehringer Ingelheim to Develop Breakthrough Therapies for Hard-to-Treat Diseases

/PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new partnership...

DNA : 1.8350 (+11.21%)
Ginkgo Bioworks Announces Appointment of Steven P. Coen as Chief Accounting Officer

/PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo" or the "Company"), which is building the leading platform for cell programming and...

DNA : 1.8350 (+11.21%)
Ligand Pharmaceuticals (LGND) Surpasses Q1 Earnings and Revenue Estimates

Ligand (LGND) delivered earnings and revenue surprises of 121.36% and 12.13%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

LGND : 72.20 (+1.69%)
DNA : 1.8350 (+11.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 1.8533
2nd Resistance Point 1.7767
1st Resistance Point 1.7133
Last Price 1.8250
1st Support Level 1.5733
2nd Support Level 1.4967
3rd Support Level 1.4333

See More

52-Week High 4.9100
Fibonacci 61.8% 3.4622
Fibonacci 50% 3.0150
Fibonacci 38.2% 2.5678
Last Price 1.8250
52-Week Low 1.1200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar